Anin SituQuantitative Immunohistochemical Study of Cytokines and IL-2R+in Chronic Human Chagasic Myocarditis: Correlation with the Presence of MyocardialTrypanosoma cruziAntigens
about
CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathyPentoxifylline reverses chronic experimental Chagasic cardiomyopathy in association with repositioning of abnormal CD8+ T-cell responseProfile of central and effector memory T cells in the progression of chronic human chagas diseaseIL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditisSelective decrease of components of the creatine kinase system and ATP synthase complex in chronic Chagas disease cardiomyopathyInduction of IL-12 production in human peripheral monocytes by Trypanosoma cruzi Is mediated by glycosylphosphatidylinositol-anchored mucin-like glycoproteins and potentiated by IFN- γ and CD40-CD40L interactions.Myocardial gene expression of T-bet, GATA-3, Ror-γt, FoxP3, and hallmark cytokines in chronic Chagas disease cardiomyopathy: an essentially unopposed TH1-type response.Chagas disease cardiomyopathy: immunopathology and genetics.Different infective forms trigger distinct immune response in experimental Chagas diseaseMyocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10.Heart-infiltrating and peripheral T cells in the pathogenesis of human Chagas' disease cardiomyopathy.Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways.Plasma cytokine expression is associated with cardiac morbidity in chagas disease.HIV-1 vaccines and co-infection.Innate and acquired immunity in the pathogenesis of Chagas disease.Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-statusAn overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress.Current status and future prospects for a vaccine against American trypanosomiasis.Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry.Chronic Trypanosoma cruzi-elicited cardiomyopathy: from the discovery to the proposal of rational therapeutic interventions targeting cell adhesion molecules and chemokine receptors--how to make a dream come true.Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy.Do Archaea and bacteria co-infection have a role in the pathogenesis of chronic chagasic cardiopathy?New diagnostic serum biomarkers for Chagas disease.Chagas disease: still many unsolved issues.Locally produced survival cytokines IL-15 and IL-7 may be associated to the predominance of CD8+ T cells at heart lesions of human chronic Chagas disease cardiomyopathy.In vitro and in vivo experimental models for drug screening and development for Chagas disease.Gap junction reduction in cardiomyocytes following transforming growth factor-beta treatment and Trypanosoma cruzi infection.The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human chagas disease.Trypanosoma cruzi infection: a continuous invader-host cell cross talk with participation of extracellular matrix and adhesion and chemoattractant molecules.Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy.Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease.Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.Immunological and pathological responses in BALB/c mice induced by genetic administration of Tc 13 Tul antigen of Trypanosoma cruzi.
P2860
Q27346448-A86B8D79-13E1-41E0-9BB1-19B122CF5EC4Q28544692-C23EF6BF-331C-4EAD-A0DD-0C8459F36179Q33501719-6FB5800E-0D2D-450D-BA7F-2EFF9DF5D0DFQ33532584-7C9831B5-4199-44B5-93D6-76A53FBC806BQ33955413-C32F8E60-1A0F-46A5-958C-D2EAC793F711Q33997924-531B8417-D5A6-4FBA-8529-4C81A5CBB870Q34053139-0EC40D8F-0759-40A1-BE61-1C6FC5ED709CQ34125557-52121BD4-AFE5-4B2A-8907-738D765B9361Q34193529-02EB611A-1CDE-4EBE-A64D-687938957767Q34476397-BF6A744D-193D-4293-AB02-6521454325B9Q34574058-143491C5-600D-4E7A-A006-62FB237600E3Q35065274-A1A88524-A3F3-42FA-B002-9C4B4E54176AQ35112727-77C9B716-E7E9-4C64-B1AC-F531CEFC6CFDQ35873784-48CA1A9A-E5B4-4C77-8905-24EF2710C763Q35994773-9025E6A0-C7C6-420D-8B97-13A9536DAA00Q36317381-8D98A87A-8A57-4051-8487-B1B829874CB4Q36338129-1A27910D-8F31-41CD-91A6-0E6A0F066D2BQ36350576-1C5E39B5-08C2-460D-B643-A5FC938F87C4Q36385476-5B317BAA-9614-4551-95B5-B69B6F71A5EFQ37597060-2E2154BC-9A81-40C1-BE74-A6E482F3A7C8Q37597069-5C63128D-1B7A-4214-8D83-921A2E1654A6Q37854271-A9350E75-B84F-423B-B2AB-71E80BE6B02FQ38088727-2502E146-44C4-4CA2-AAD8-145B6E004758Q38238078-F8B6F91D-C398-4E79-9448-316E5B1EE58FQ40106363-BE329CBF-350E-44D1-B685-3033C31DE0EEQ43080976-CB343570-9414-4775-935E-7A6032CE565CQ43169573-A1A4662F-393C-40D7-AE0E-E4F6BD6E0B0DQ44537491-DF77E48A-8583-4C21-8554-36CDD29A0F23Q44936820-96541773-8878-41D6-8769-2E9E84AF02E4Q47758399-20B361E0-B1EE-4297-B066-FD7F8367D110Q47883122-94787CC7-06B2-46ED-8485-8FC7CA529B2EQ51969941-75B099C7-17EB-418C-ADA0-31023EF1EF42Q51984774-C51FCF82-3324-49D4-9D74-9C426A4DE106
P2860
Anin SituQuantitative Immunohistochemical Study of Cytokines and IL-2R+in Chronic Human Chagasic Myocarditis: Correlation with the Presence of MyocardialTrypanosoma cruziAntigens
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 1997
@uk
name
Anin SituQuantitative Immunohi ...... rdialTrypanosoma cruziAntigens
@en
Anin SituQuantitative Immunohi ...... rdialTrypanosoma cruziAntigens
@nl
type
label
Anin SituQuantitative Immunohi ...... rdialTrypanosoma cruziAntigens
@en
Anin SituQuantitative Immunohi ...... rdialTrypanosoma cruziAntigens
@nl
prefLabel
Anin SituQuantitative Immunohi ...... rdialTrypanosoma cruziAntigens
@en
Anin SituQuantitative Immunohi ...... rdialTrypanosoma cruziAntigens
@nl
P2093
P50
P356
P1476
Anin SituQuantitative Immunohi ...... rdialTrypanosoma cruziAntigens
@en
P2093
Fulvio Pileggi
Giovanni Bellotti
Luiz Alberto Benvenuti
Vera Demarchi Aiello
P304
P356
10.1006/CLIN.1997.4335
P577
1997-05-01T00:00:00Z